ABEO Shares Outstanding History
Below is a table of the ABEO shares outstanding history going back to 10/24/2014:

Date ABEO Shares Outstanding
10/24/20140.53M
11/14/2014536589
12/19/201413.31M
3/30/201519.99M
5/14/201524.27M
8/14/201532.69M
11/16/201532.73M
3/30/201632.74M
5/16/201632.80M
8/15/201633.55M
11/14/201639.96M
3/30/201740.26M
5/15/201740.26M
8/11/201740.29M
11/13/201746.78M
3/15/201847.23M
5/10/201847.31M
8/9/201847.94M
11/9/201847.94M

Also see: ABEO Market Cap History
and ABEO YTD Return
ABEO Historical Shares Outstanding:
+204.06% CAGR
ABEO Historical Shares Outstanding: +204.06% CAGR

Mouse over chart for data details
10/24/2014 ...11/9/2018
Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s main programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). Co. is also developing ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL), and ABO-202 (AAV-CLN1) for treatment of infantile Batten disease (INCL), among others. We show 19 historical shares outstanding datapoints in our coverage of ABEO's shares outstanding history.

Understanding the changing numbers of ABEO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ABEO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ABEO by allowing them to research ABEO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ABEO:
ABEO SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Abeona Therapeutics (ABEO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ABIO Shares Outstanding History
ABMD Shares Outstanding History
ABT Shares Outstanding History
ACAD Shares Outstanding History
ACER Shares Outstanding History
ACET Shares Outstanding History
ACHC Shares Outstanding History
ACHN Shares Outstanding History
ACHV Shares Outstanding History
ACOR Shares Outstanding History
More Healthcare companies »

 

ABEO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2018, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.